Shopping Cart 0
Cart Subtotal
USD 0

Brigham and Womens Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Brigham and Women's Hospital (BWH) is a healthcare service provider that offers patient care services. The hospital offers care coordination, ethics consultation, interpreter services, Kessler library, nutrition, patient and family relations, pharmacy, security and safety, and spiritual care services. It offers services in the areas of anesthesiology, cancer, dermatology, emergency medicine, medicine, neurology, neurosurgery, obstetrics and gynecology; orthopedic surgery, pathology, pediatric newborn medicine, radiation oncology, radiology, surgery, women's health and others. The hospital serves patients from New England. BWH is headquartered in Boston, Massachusetts, the US.

Brigham and Women's Hospital-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Brigham and Women's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Brigham and Women's Hospital, Medical Devices Deals, 2012 to YTD 2018 10

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

BERG, Massachusetts General Hospital and Brigham and Women's Hospital Enter into Research Agreement 13

Spotlight Innovation Enters into Research Agreement with Brigham and Women's Hospital 14

LEO Science & Tech Hub Enters into Partnership with Karp Lab 15

Abpro Enters into Co-Development Agreement with Brigham and Women's Hospital 16

Transition Therapeutics Enters into Agreement with Brigham and Women's Hospital 17

GeneInsight Enters into Agreement with Brigham and Women's Hospital 18

Jiahui International Hospital, Partners HealthCare International and Brigham and Women's Hospital to Co-Develop Women's Health Center 19

biOasis Technologies Enters into Research Agreement with Brigham and Women's Hospital 20

Veristat Partners with Multi-Regional Clinical Trials Center 21

Sanofi Enters Into Research Agreement With Brigham and Women's Hospital 22

Evotec Enters Into Co-Development Agreement With Harvard University And BWH 23

Licensing Agreements 25

StemCell Technologies Enters into Licensing Agreement with Brigham and Women's Hospital 25

Tiziana Life Sciences Enters into Licensing Agreement with Brigham and Women's Hospital 26

H&P Labs Enters into Licensing Agreement with Harvard University and Brigham and Women's Hospital 27

Brigham and Women's Hospital-Key Competitors 28

Brigham and Women's Hospital-Key Employees 29

Brigham and Women's Hospital-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Joint Venture 31

Recent Developments 32

Government and Public Interest 32

Aug 14, 2018: Drug Repurposing Study Sheds Light on Heart Disease Risk 32

Aug 09, 2018: Potential Solutions to Drug Shortages and the Lack of Competition in Generic Medicines 33

Aug 06, 2018: A targeted approach to treating glioma 34

Aug 02, 2018: Newly characterized molecule offers possibilities for novel Alzheimer's treatments 35

Jul 30, 2018: Advancing the Search for Antibodies to Treat Alzheimer's Disease 36

Jun 20, 2018: Study Explores Satisfaction, Quality of Life after Breast Reconstruction 37

May 18, 2018: Downward-Facing Mouse: Stretching Reduces Tumor Growth in Mouse Model of Breast Cancer 38

Apr 19, 2018: 3-D Human "Mini-Brains" Shed New Light on Genetic Underpinnings of Major Mental Illness 39

Apr 10, 2018: Blood Test May Predict Future Risk of Cardiovascular Events 40

Mar 05, 2018: Cognitive decline prevalent among elderly patients with hematologic cancers, study finds 41

Mar 02, 2018: Gastric bypass surgery can give better control for diabetes and obesity than lifestyle modification 42

Jan 18, 2018: Vanderbilt University Medical Center secures grant to address the challenges of limb problems in peripheral artery disease 44

Jan 09, 2018: New drug capsule may allow weekly HIV treatment 46

Dec 07, 2017: Shorter Course of Treatment May Provide Better Outcome for Men with Intermediate-Risk Prostate Cancer 48

Oct 31, 2017: From Bench to Bedside: USD 4 Million Gift Supports Translational Medicine 49

Oct 09, 2017: New Congenital Heart Disease Genes Uncovered 50

Oct 05, 2017: Better understanding of bladder cancer subtypes might lead to improved treatments 51

Sep 28, 2017: Neuro-Immune Crosstalk in Allergic Asthma 52

Sep 19, 2017: Scripps Florida Scientist Awarded USD 2.5 Million Collaborative Grant to Develop New Diabetes Treatment 54

Sep 14, 2017: Insulin therapy initially declined and delayed by an average of 2 years 55

Sep 12, 2017: Menopausal hormone therapy not associated with mortality or deaths from CVD 56

Sep 12, 2017: Three New Grants Support Promising Treatments for Alzheimers Disease 57

Aug 22, 2017: Studies highlight 'potential new targets for immunotherapy' 58

Jul 13, 2017: Using a Microrna to Shift the Makeup of Glioblastoma Subtypes 59

Jul 10, 2017: New approach shows promising results for stem cell-based therapy for skin-to-brain cancer in preclinical models 60

May 15, 2017: USD 2.6 Million in New Grants Spurs Innovation 61

Mar 07, 2017: USD 4 Million in New Grants Support Several First-in-class Dementia Treatments 64

Product News 67

Aug 31, 2017: Drugs targeting the beta2-adrenoreceptor linked to Parkinson's disease 67

Aug 06, 2018: Researchers claim to have uncovered how thalidomide caused birth defects 68

Jul 02, 2018: New Cancer Immunotherapy Shows Promise in Early Tests 69

Apr 30, 2018: Entrinsic Health Solutions and Brigham and Women's Hospital Launch Pilot Study in Patients with Inflammatory Bowel Disease 70

Jan 09, 2018: Slow-Release Pill Developed to Deliver HIV Therapeutics 71

Appendix 72

Methodology 72

About GlobalData 72

Contact Us 72

Disclaimer 72


List Of Figure

List of Figures

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Brigham and Women's Hospital, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Key Facts 2

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Brigham and Women's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Brigham and Women's Hospital, Deals By Therapy Area, 2012 to YTD 2018 9

Brigham and Women's Hospital, Medical Devices Deals, 2012 to YTD 2018 10

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

BERG, Massachusetts General Hospital and Brigham and Women's Hospital Enter into Research Agreement 13

Spotlight Innovation Enters into Research Agreement with Brigham and Women's Hospital 14

LEO Science & Tech Hub Enters into Partnership with Karp Lab 15

Abpro Enters into Co-Development Agreement with Brigham and Women's Hospital 16

Transition Therapeutics Enters into Agreement with Brigham and Women's Hospital 17

GeneInsight Enters into Agreement with Brigham and Women's Hospital 18

Jiahui International Hospital, Partners HealthCare International and Brigham and Women's Hospital to Co-Develop Women's Health Center 19

biOasis Technologies Enters into Research Agreement with Brigham and Women's Hospital 20

Veristat Partners with Multi-Regional Clinical Trials Center 21

Sanofi Enters Into Research Agreement With Brigham and Women's Hospital 22

Evotec Enters Into Co-Development Agreement With Harvard University And BWH 23

StemCell Technologies Enters into Licensing Agreement with Brigham and Women's Hospital 25

Tiziana Life Sciences Enters into Licensing Agreement with Brigham and Women's Hospital 26

H&P Labs Enters into Licensing Agreement with Harvard University and Brigham and Women's Hospital 27

Brigham and Women's Hospital, Key Competitors 28

Brigham and Women's Hospital, Key Employees 29

Brigham and Women's Hospital, Other Locations 30

Brigham and Women's Hospital, Joint Venture 31

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Brigham and Women's Hospital, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Brigham and Women's Hospital (BWH) is a healthcare service provider that offers patient care services. The hospital offers care coordination, ethics consultation, interpreter services, Kessler library, nutrition, patient and family relations, pharmacy, security and safety, and spiritual care services. It offers services in the areas of anesthesiology, cancer, dermatology, emergency medicine, medicine, neurology, neurosurgery, obstetrics and gynecology; orthopedic surgery, pathology, pediatric newborn medicine, radiation oncology, radiology, surgery, women's health and others. The hospital serves patients from New England. BWH is headquartered in Boston, Massachusetts, the US.

Brigham and Women's Hospital-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Brigham and Women's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Brigham and Women's Hospital, Medical Devices Deals, 2012 to YTD 2018 10

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

BERG, Massachusetts General Hospital and Brigham and Women's Hospital Enter into Research Agreement 13

Spotlight Innovation Enters into Research Agreement with Brigham and Women's Hospital 14

LEO Science & Tech Hub Enters into Partnership with Karp Lab 15

Abpro Enters into Co-Development Agreement with Brigham and Women's Hospital 16

Transition Therapeutics Enters into Agreement with Brigham and Women's Hospital 17

GeneInsight Enters into Agreement with Brigham and Women's Hospital 18

Jiahui International Hospital, Partners HealthCare International and Brigham and Women's Hospital to Co-Develop Women's Health Center 19

biOasis Technologies Enters into Research Agreement with Brigham and Women's Hospital 20

Veristat Partners with Multi-Regional Clinical Trials Center 21

Sanofi Enters Into Research Agreement With Brigham and Women's Hospital 22

Evotec Enters Into Co-Development Agreement With Harvard University And BWH 23

Licensing Agreements 25

StemCell Technologies Enters into Licensing Agreement with Brigham and Women's Hospital 25

Tiziana Life Sciences Enters into Licensing Agreement with Brigham and Women's Hospital 26

H&P Labs Enters into Licensing Agreement with Harvard University and Brigham and Women's Hospital 27

Brigham and Women's Hospital-Key Competitors 28

Brigham and Women's Hospital-Key Employees 29

Brigham and Women's Hospital-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Joint Venture 31

Recent Developments 32

Government and Public Interest 32

Aug 14, 2018: Drug Repurposing Study Sheds Light on Heart Disease Risk 32

Aug 09, 2018: Potential Solutions to Drug Shortages and the Lack of Competition in Generic Medicines 33

Aug 06, 2018: A targeted approach to treating glioma 34

Aug 02, 2018: Newly characterized molecule offers possibilities for novel Alzheimer's treatments 35

Jul 30, 2018: Advancing the Search for Antibodies to Treat Alzheimer's Disease 36

Jun 20, 2018: Study Explores Satisfaction, Quality of Life after Breast Reconstruction 37

May 18, 2018: Downward-Facing Mouse: Stretching Reduces Tumor Growth in Mouse Model of Breast Cancer 38

Apr 19, 2018: 3-D Human "Mini-Brains" Shed New Light on Genetic Underpinnings of Major Mental Illness 39

Apr 10, 2018: Blood Test May Predict Future Risk of Cardiovascular Events 40

Mar 05, 2018: Cognitive decline prevalent among elderly patients with hematologic cancers, study finds 41

Mar 02, 2018: Gastric bypass surgery can give better control for diabetes and obesity than lifestyle modification 42

Jan 18, 2018: Vanderbilt University Medical Center secures grant to address the challenges of limb problems in peripheral artery disease 44

Jan 09, 2018: New drug capsule may allow weekly HIV treatment 46

Dec 07, 2017: Shorter Course of Treatment May Provide Better Outcome for Men with Intermediate-Risk Prostate Cancer 48

Oct 31, 2017: From Bench to Bedside: USD 4 Million Gift Supports Translational Medicine 49

Oct 09, 2017: New Congenital Heart Disease Genes Uncovered 50

Oct 05, 2017: Better understanding of bladder cancer subtypes might lead to improved treatments 51

Sep 28, 2017: Neuro-Immune Crosstalk in Allergic Asthma 52

Sep 19, 2017: Scripps Florida Scientist Awarded USD 2.5 Million Collaborative Grant to Develop New Diabetes Treatment 54

Sep 14, 2017: Insulin therapy initially declined and delayed by an average of 2 years 55

Sep 12, 2017: Menopausal hormone therapy not associated with mortality or deaths from CVD 56

Sep 12, 2017: Three New Grants Support Promising Treatments for Alzheimers Disease 57

Aug 22, 2017: Studies highlight 'potential new targets for immunotherapy' 58

Jul 13, 2017: Using a Microrna to Shift the Makeup of Glioblastoma Subtypes 59

Jul 10, 2017: New approach shows promising results for stem cell-based therapy for skin-to-brain cancer in preclinical models 60

May 15, 2017: USD 2.6 Million in New Grants Spurs Innovation 61

Mar 07, 2017: USD 4 Million in New Grants Support Several First-in-class Dementia Treatments 64

Product News 67

Aug 31, 2017: Drugs targeting the beta2-adrenoreceptor linked to Parkinson's disease 67

Aug 06, 2018: Researchers claim to have uncovered how thalidomide caused birth defects 68

Jul 02, 2018: New Cancer Immunotherapy Shows Promise in Early Tests 69

Apr 30, 2018: Entrinsic Health Solutions and Brigham and Women's Hospital Launch Pilot Study in Patients with Inflammatory Bowel Disease 70

Jan 09, 2018: Slow-Release Pill Developed to Deliver HIV Therapeutics 71

Appendix 72

Methodology 72

About GlobalData 72

Contact Us 72

Disclaimer 72


List Of Figure

List of Figures

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Brigham and Women's Hospital, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Key Facts 2

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Brigham and Women's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Brigham and Women's Hospital, Deals By Therapy Area, 2012 to YTD 2018 9

Brigham and Women's Hospital, Medical Devices Deals, 2012 to YTD 2018 10

Brigham and Women's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

BERG, Massachusetts General Hospital and Brigham and Women's Hospital Enter into Research Agreement 13

Spotlight Innovation Enters into Research Agreement with Brigham and Women's Hospital 14

LEO Science & Tech Hub Enters into Partnership with Karp Lab 15

Abpro Enters into Co-Development Agreement with Brigham and Women's Hospital 16

Transition Therapeutics Enters into Agreement with Brigham and Women's Hospital 17

GeneInsight Enters into Agreement with Brigham and Women's Hospital 18

Jiahui International Hospital, Partners HealthCare International and Brigham and Women's Hospital to Co-Develop Women's Health Center 19

biOasis Technologies Enters into Research Agreement with Brigham and Women's Hospital 20

Veristat Partners with Multi-Regional Clinical Trials Center 21

Sanofi Enters Into Research Agreement With Brigham and Women's Hospital 22

Evotec Enters Into Co-Development Agreement With Harvard University And BWH 23

StemCell Technologies Enters into Licensing Agreement with Brigham and Women's Hospital 25

Tiziana Life Sciences Enters into Licensing Agreement with Brigham and Women's Hospital 26

H&P Labs Enters into Licensing Agreement with Harvard University and Brigham and Women's Hospital 27

Brigham and Women's Hospital, Key Competitors 28

Brigham and Women's Hospital, Key Employees 29

Brigham and Women's Hospital, Other Locations 30

Brigham and Women's Hospital, Joint Venture 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Brigham and Women's Hospital, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.